Webhealth
Webhealth has been specifically developed to provide access for people to
connect with Health and Social Services. This web-based approach builds on
the strengths of people and families to determine their support needs. Within the Webhealth website is Linkage. Linkage is a
partnership between an NGO, Pathways; primary health care, Pinnacle; and a
secondary provider/hospital, Health Waikato. It offers early intervention
services with a “one stop shop” in central Hamilton and New Plymouth.
Wednesday, January 07, 2004
December 29 AP story reprinted at PsycPORT - "Eli Lilly and Co. on Monday said it has won regulatory approval to sell its new drug Symbyax to treat the depressive phase of bipolar disorder. The U.S. Food and Drug Administration approved the drug, which is a combination of the active ingredients in two other drugs - the anti-depressant Prozac and the anti-psychotic Zyprexa, which is used for treating manic stages of bipolar disorder. Symbyax treats the depression stages of the illness without triggering mania, said Marni Lemons, a spokeswoman for the Indianapolis-based drug company. "
comment []
December 18 SAMHSA press release - " The Substance Abuse and Mental Health Services Administration (SAMHSA) is accepting grant applications for fiscal year 2004 to provide funding for family and consumer networks that support effective substance abuse and mental health service delivery to address the needs of children and adolescents with serious emotional disturbances, and their families. SAMHSA anticipates that there will be $2.8million available in 2004 for 43 Statewide Family Network grants, with a limit of one award per state, of up to $60,000 per year. In addition, there will be $1.5 million available in 2004 for 20-22 statewide Consumer Network Grants of up to $70,000 per year, with a limit of one award per state." The application deadline is February 25.
comment []
Health Central story - "Patients who engage in cognitive or 'talk; therapy to recover from depression show brain changes that differ from what occurs with drug therapy, new research finds. The study shows for the first time with imaging evidence that the depressed brain responds differently to different treatments -- and the results may help doctors understand why one treatment works for one patient but not another, says study author Dr. Helen Mayberg. Her report appears in the January issue of the Archives of General Psychiatry."
comment []
Copyright 2003 © Bill Davis.
IIMHL Update is a project done in collaboration with MHCA and the Centre for Community Change International. IIMHL Update is powered by Radio Userland.